Usefulness of serum protein profiling for prediction of preoperative chemoradiosensitivity of esophageal cancer.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Oncology Report

• Publication date

  2007-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/OR.18.3.653PMID 17671715
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guide lines for the clinical and pathologic studies for carcinoma of the esophagus

  2006cited by this paper
• Possible Prediction of Chemoradiosensitivity of Esophageal Cancer by Serum Protein Profiling

  2005cited by this paper
• Effectiveness of Preoperative Chemoradiotherapy for Advanced Esophageal Carcinoma

  2004cited by this paper
• Concurrent preoperative chemoradiotherapy for stage III or IV esophageal squamous carcinoma.

  2004cited by this paper
• Predictive factors for response to neoadjuvant therapy in patients with oesophageal cancer.

  2002cited by this paper
• Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer.

  2002cited by this paper
• Preoperative concurrent chemotherapy and radiation therapy followed by surgery for esophageal cancer.

  2002cited by this paper
• [Neoadjuvant chemoradiotherapy in patients with surgically treated T4 esophageal squamous cell carcinnoma].

  2002cited by this paper
• Prediction of the response to chemoradiation and prognosis in oesophageal squamous cancer

  2002cited by this paper
• Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma: Response Evaluation by Positron Emission Tomography

  2001cited by this paper
• Diagnostic image for neoadjuvant chemo (radiation) therapies toward advanced esophageal cancers

  2001cited by this paper
• Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer

  1999cited by this paper
• Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer

  1999cited by this paper
• Improving protein identification from peptide mass fingerprinting through a parameterized multi‐level scoring algorithm and an optimized peak detection

  1999cited by this paper
• Radiochemosensitivity and expression of p53 in patients with esophageal cancer treated by absolute noncurative resection.

  1998cited by this paper
• Chemotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus

  1998cited by this paper
• Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.

  1997cited by this paper
• A prospective study of combined therapy in esophageal cancer.

  1994cited by this paper
• A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus

  1994cited by this paper
• p53 status and the efficacy of cancer therapy in vivo.

  1994cited by this paper

• Serum differential protein identification of Xinjiang Kazakh esophageal cancer patients based on the two-dimensional liquid-phase chromatography and LTQ MS

  2014cites this paper
• Tumor response after low-dose preoperative radiotherapy combined with chemotherapy for squamous cell esophageal carcinoma.

  2013cites this paper
• Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer

  2012cites this paper
• Proposal of a Punch Biopsy Protocol as a Pre-requisite for the Establishment of a Tissue Bank from Resected Esophageal Tumors

  2010cites this paper
• Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy

  2010cites this paper
• Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy.

  2009cites this paper